Simba-comib Tablet 10/20mg
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Dong-gu Bio Pharmaceutical Co., Ltd.
MFDS item code 201007249 · Notified 2010.11.29
This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication helps lower elevated total cholesterol and LDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia, while increasing HDL cholesterol. It can be used alone or as an adjunct to other treatments for patients with severe homozygous familial hypercholesterolemia, effectively controlling blood cholesterol levels. This medication should be used in conjunction with a diet and is recommended when dietary treatment alone is insufficient. It is administered cautiously to patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. Before administration, secondary causes such as diabetes and hypothyroidism should be evaluated and treated if necessary. Treatment efficacy should be monitored by checking total cholesterol, LDL, HDL, and triglyceride levels, and it can also be appropriately applied to patients with cardiovascular events. Therefore, this medication is effective in improving cholesterol levels and enhancing cardiovascular health.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this medicine is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start at 10/10mg once daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is used as an adjunct to other lipid-lowering therapies (e.g., LDL Apheresis) or when other lipid-lowering therapies are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary when administering this medicine to older adults. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication is primarily used to lower blood cholesterol levels. Muscle pain or weakness may occur during treatment, and rarely, a serious condition called rhabdomyolysis can develop, resulting in severe muscle damage. The risk can be heightened, especially when taken in high doses or in conjunction with specific medications. Patients with liver function issues or elevated liver enzyme levels should not take this medication, and regular testing is necessary if liver dysfunction is suspected. Women who are pregnant or nursing should not take this medication, and women of childbearing age must confirm pregnancy status before use. This medication can lead to higher blood concentrations when taken with drugs that inhibit certain enzymes (CYP3A4), thus increasing the risk of side effects. Therefore, patients should consult a physician if they are under treatment with such drugs. Additionally, interactions with certain anticoagulants, specific antibiotics, and calcium channel blockers exist; patients taking other medications should notify their healthcare providers. If unexplained muscle pain, muscle weakness, changes in urine color, or other adverse symptoms occur, patients should immediately notify a physician and discontinue treatment. This medication should also be used cautiously in elderly patients or those with reduced kidney function, and regular blood tests to monitor liver and muscle condition are advisable. In cases of overdose, there is no specific antidote, and immediate medical attention is necessary for appropriate treatment. Finally, it is advisable to limit the intake of certain foods, such as grapefruit juice, while taking this medication and to inform other healthcare providers about its use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature.
White to whitish convex rectangular tablets on both sides
30 tablets (10 tablets/Alu-Alu*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Dong-gu Bio Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.